Leap Therapeutics, Inc. (LPTX)
| Market Cap | 102.45M |
| Revenue (ttm) | 1.13M |
| Net Income (ttm) | -41.83M |
| Shares Out | 88.32M |
| EPS (ttm) | -0.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 249,032 |
| Open | 1.16 |
| Previous Close | 1.16 |
| Day's Range | 1.13 - 1.21 |
| 52-Week Range | 0.92 - 4.17 |
| Beta | 0.57 |
| Analysts | Buy |
| Price Target | 4.49 (+287.1%) |
| Earnings Date | Aug 11, 2022 |
About LPTX
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly kn... [Read more...]
Financial Performance
In 2021, LPTX's revenue was $1.50 million, a change of 0.00% compared to the previous year's $1.50 million. Losses were -$40.59 million, 47.5% more than in 2020.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for LPTX stock is "Buy." The 12-month stock price forecast is 4.49, which is an increase of 287.07% from the latest price.
News
Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endomet...
Randomized Controlled First-Line Gastric Cancer Trial of DKN-01 plus tislelizumab and chemotherapy in collaboration with BeiGene Leap to host R&D Day today at 12:00 p.m. ET CAMBRIDGE, Mass.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
Want to try an out-of-the-box approach? Tap Oncolytics Biotech (ONCY), Pediatrix Medical Group Inc (MD), Boot Barn (BOOT), Canada Goose (GOOS) and Leap Therapeutics (LPTX).
Leap Therapeutics to Host Virtual R&D Day on July 12, 2022
CAMBRIDGE, Mass. , June 27, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it ...
Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients ...
CAMBRIDGE, Mass. , May 26, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that init...
Leap Therapeutics Reports First Quarter 2022 Financial Results
CAMBRIDGE, Mass. , May 13, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial r...
Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April
Check these three penny stocks out for your watchlist right now The post Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April appeared first on Penny Stocks to Buy, Picks, News and Inf...
Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
CAMBRIDGE, Mass., March 11, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial ...
Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference
CAMBRIDGE, Mass., March 2, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Doug...
Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference
CAMBRIDGE, Mass., Jan. 24, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dougl...
Why Leap Therapeutics Stock Is Surging Today
Positive clinical trial results are giving investors a reason to cheer.
These 2 Nasdaq Stocks Are Poised to Make Big Moves Today
These clinical-stage biotech stocks are headed in opposite directions today.
Leap Therapeutics Says DKN-01 Combo Regime Show Compelling Efficacy In Gastric Cancer Patients
Leap Therapeutics Inc (NASDAQ: LPTX) will present updated data from the DisTinGuish Phase 2a study of DKN-01, in combination with tislelizumab in gastric or gastric gastroesophageal junction cancer (G/G...
Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI ...
CAMBRIDGE, Mass., Jan. 18, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Compa...
2 Risky Growth Stocks That Could Make You Filthy Rich
These two biotech stocks are set to report key clinical data later this year.
Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference
CAMBRIDGE, Mass., Jan. 5, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dougl...
Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 3, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dougl...
Top Penny Stocks To Buy According To Analysts & Targets Up To 615%
Penny stocks with hight hopes from analysts. The post Top Penny Stocks To Buy According To Analysts & Targets Up To 615% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks....
Best Penny Stocks To Buy Now For A Short Squeeze? 5 To Watch
Looking for short squeeze penny stocks? Give these 5 a look.
Hot Biotech Penny Stocks to Watch As New Variant Creates Volatility
Check these three biotech penny stocks out for your list this month The post Hot Biotech Penny Stocks to Watch As New Variant Creates Volatility appeared first on Penny Stocks to Buy, Picks, News and In...
Leap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
CAMBRIDGE, Mass. , Nov. 15, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that memb...
Leap Therapeutics Reports Third Quarter 2021 Financial Results
CAMBRIDGE, Mass., Nov. 12, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial r...
Earnings Preview: Leap Therapeutics, Inc. (LPTX) Q3 Earnings Expected to Decline
Leap Therapeutics, Inc. (LPTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Best Short Squeeze Penny Stocks To Buy? 4 To Watch Right Now
Are these the top penny stocks to watch for a short squeeze? The post Best Short Squeeze Penny Stocks To Buy?
2 Penny Stocks That Could Soar Soon
These two tiny drugmakers might be hidden gems.